“Vaccine Fatigue”? Merck Bets $9.2 Billion on “Not-a-Vaccine” Flu Drug
Merck is paying $9.2 billion to acquire a drug company primarily for an experimental antiviral flu-prevention ...
Read moreDetails
Tag: Merck
In Case You Needed More Evidence of the PLANdemic, Merck’s Covid-19 Pill Molnupiravir Is CAUSING New Mutations
A new study has found that Merck’s Wuhan coronavirus (COVID-19) drug molnupiravir, sold under the brand ...
Read moreDetails